GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-09 22:10 |
GENFIT : Information financière du troisième trimestre 2023
|
French | 166.6 KB | ||
| 2023-11-09 22:10 |
GENFIT Reports Third Quarter 2023 Financial Information
|
English | 261.7 KB | ||
| 2023-11-02 22:10 |
GENFIT présente ses avancées scientifiques et stratégiques au congrès internati…
|
French | 189.1 KB | ||
| 2023-11-02 22:10 |
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meet…
|
English | 168.5 KB | ||
| 2023-09-26 22:10 |
GENFIT annonce une publication dans Nature Medicine confirmant la performance d…
|
French | 233.2 KB | ||
| 2023-09-26 22:10 |
GENFIT Announces Publication in Nature Medicine Confirming the Performance of i…
|
English | 186.9 KB | ||
| 2023-09-20 22:10 |
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Up…
|
English | 501.0 KB | ||
| 2023-09-20 22:10 |
GENFIT : Résultats financiers du premier semestre 2023 et point sur les activit…
|
French | 473.8 KB | ||
| 2023-09-20 22:00 |
Rapport d'Activité et Financier semestriel 2023 - Attestation du Responsable
|
French | 322.0 KB | ||
| 2023-09-05 22:10 |
GENFIT annonce sa participation aux prochaines conférences investisseurs
|
French | 125.1 KB | ||
| 2023-09-05 22:10 |
GENFIT to Participate in Upcoming Investor Conferences
|
English | 147.0 KB | ||
| 2023-08-10 22:10 |
GENFIT annonce la publication de nouvelles données sur la performance clinique …
|
French | 168.5 KB | ||
| 2023-08-10 22:10 |
GENFIT Announces the Publication of New Data on the Clinical Performance of NIS…
|
English | 187.7 KB | ||
| 2023-07-13 16:09 |
Franchissement de seuil
|
French | 263.0 KB | ||
| 2023-07-12 22:10 |
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commer…
|
English | 294.1 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
